KRKA, d.d., Novo Mesto (manufacturing 'in bulk', primary and secondary packaging, batch control and batch release)/KRKA, d.d., Novo Mesto (batch control)
UkraineAll medications by this manufacturer
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 10 mg ATC: C10AA05
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 20 mg ATC: C10AA05
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 40 mg ATC: C10AA05
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 30 mg ATC: C10AA05
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 60 mg ATC: C10AA05
-
Atoris
Form: tablets, film-coated
Active substance Dosage atorvastatin 80 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 10 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 20 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 40 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 30 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 60 mg ATC: C10AA05
-
Atorvastatin krka
Form: tablets, film-coated
Active substance Dosage atorvastatin 80 mg ATC: C10AA05
-
Flebaven® 500
Form: tablets, film-coated
Active substance Dosage diosmin 500 mg ATC: C05CA03
-
Fromilid
Form: tablets, film-coated
Active substance Dosage clarithromycin 250 mg ATC: J01FA09
-
Fromilid
Form: tablets, film-coated
Active substance Dosage clarithromycin 500 mg ATC: J01FA09
-
Linezolid krka
Form: tablets, film-coated
Active substance Dosage linezolid 600 mg ATC: J01XX08
-
Moflaxa
Form: solution for infusion
Active substance Dosage moxifloxacin 1.6 mg/ml ATC: J01MA14
-
Nolpaza®
Form: tablets, enteric-coated
Active substance Dosage pantoprazole 20 mg ATC: A02BC02
-
Nolpaza®
Form: tablets, enteric-coated
Active substance Dosage pantoprazole 40 mg ATC: A02BC02
-
Nolpaza® control
Form: tablets, enteric-coated
Active substance Dosage pantoprazole 20 mg ATC: A02BC02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 25 mg ATC: N02BF02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 50 mg ATC: N02BF02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 75 mg ATC: N02BF02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 150 mg ATC: N02BF02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 200 mg ATC: N02BF02
-
Pregabio®
Form: capsules
Active substance Dosage pregabalin 300 mg ATC: N02BF02
-
Prenesa
Form: tablets
Active substance Dosage perindopril 2 mg ATC: C09AA04
-
Prenesa®
Form: tablets
Active substance Dosage perindopril 4 mg ATC: C09AA04
-
Prenesa®
Form: tablets
Active substance Dosage perindopril 8 mg ATC: C09AA04
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 5 mg ATC: C10AA07
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ATC: C10AA07
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ATC: C10AA07
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ATC: C10AA07
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 15 mg ATC: C10AA07
-
Rosuvastatin krka
Form: tablets, film-coated
Active substance Dosage rosuvastatin 30 mg ATC: C10AA07
-
Telmista
Form: tablets
Active substance Dosage telmisartan 20 mg ATC: C09CA07
-
Telmista
Form: tablets
Active substance Dosage telmisartan 40 mg ATC: C09CA07
-
Telmista
Form: tablets
Active substance Dosage telmisartan 80 mg ATC: C09CA07